<DOC>
	<DOCNO>NCT00270829</DOCNO>
	<brief_summary>The impact nesiritide CHF unclear , possible systemic vasodilation lead adverse consequence even direct renal effect positive . Therefore , study look effect direct intrarenal administration nesiritide GFR RPF .</brief_summary>
	<brief_title>Renal Effects Intrarenal Nesiritide</brief_title>
	<detailed_description>We perform open-label , parallel arm , control study intrarenal nesiritide 26 patient hospitalize CHF . Patients admit CHF exacerbation randomly equally divide treatment placebo group . Both arm receive diuretic admission dictate clinical need . They 8-hour diuretic-free period ( overnight ) . Each arm renal parameter ( GFR , RPF , urine output , urinary sodium excretion ) assess use PAH iothalamate . These parameter measure prior administration drug period 1 . Randomization perform via interactive computerized call program follow completion screen procedure patient give informed consent . At time 0 , treatment patient take cardiac catheterization lab placement Benephit Infusion System ( Flow Medica ) . Placement involve femoral artery cannulation introduction bifurcate infusion catheter arterial system destination level renal artery . This do fluoroscopic guidance . When placement catheter complete , period 2 begin initiation Study Drug infusion ( IR nesiritide IV D5W ) . Nesiritide dilute accord label instruction D5W final dilution 6 mcg/mL . Placebo patient receive IV D5W bolus continuous infusion D5W volume equal would get randomized nesiritide . Intra-renal ( IR ) infusion nesiritide give 2ug/kg bolus follow infusion 0.01 mg/kg/min intrarenal catheter . The nesiritide infusion continue 6 hour . Period 3 begin 3-hour mark , time , placebo treatment group treat bolus intravenous furosemide . Both treatment arm receive furosemide time . Blood draw 3 6 hour urine collect 3 6 hour use determine GFR , RPF , Na excretion urine output .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Hospitalized worsen CHF volume overload Creatinine increase great equal 0.2 great equal 10 % baseline study initiation Age great equal 18 year NHYA class IIIV time initiation study EF le equal 40 % Signed Informed Consent Current anticipate need dialysis study period Systolic blood pressure less equal 90 mmHg Calculated CrCL base CockcroftGault less equal 15 cc/min Hypersensitivity nesiritide Cardiogenic shock Clinically significant aortic mitral stenosis Contraindication vasodilator treatment Inability withstand 1115 hour without diuretic Suspected renal deterioration due cause unrelated CHF radiocontrast administration , NSAID use Receipt dose NSAID within 12 hour study drug initiation Use radiocontrast medium within 7 day study drug initiation ( small amount IV contrast need place intrarenal catheter level renal artery ) Use nephrotoxic drug aminoglycosides cisplatinum within 7 day study initiation Use sildenafil PDE5 inhibitor within 24 hour study drug initiation Diseases weak collagen ( i.e . Marfans ) Aortic renal aneurysm Significant calcification region renal ostia , condition would , opinion investigator , increase risk placement intravascular sheath catheter . Known bleed diathesis Solitary kidney solitary functioning kidney Known uncorrected renal artery stenosis great 50 % either renal artery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>renal function</keyword>
</DOC>